Drospirenone and Ethinyl Estradiol Tablets USP 28 0.03 mg (Ethinyl Estradiol TABLET) 0.03 MG

Drospirenone and Ethinyl Estradiol Tablets USP 28 0.03 mg are oral contraceptive pills designed for hormonal birth control. These tablets combine two active ingredients to prevent ovulation and offer additional benefits for hormonal balance.

Strength

0.03 MG

Manufacturer / TM Owner

GLENMARK PHARMACEUTICALS CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Drospirenone and Ethinyl Estradiol Tablets are primarily used for birth control. They work by preventing ovulation and altering cervical mucus to hinder sperm movement. These tablets may also be prescribed to manage menstrual irregularities and symptoms of premenstrual dysphoric disorder (PMDD).

Side Effects

Common effects of Drospirenone and Ethinyl Estradiol Tablets may include nausea, breast tenderness, headaches, and changes in menstrual bleeding patterns. Some users may experience mood swings or bloating. These effects vary and typically subside as the body adjusts to the medication.

Precautions & Warnings

It is important to use Drospirenone and Ethinyl Estradiol Tablets as directed by a healthcare provider. Regular follow-ups are recommended to monitor for potential side effects. Avoid smoking while using these tablets, especially if over 35 years old, due to increased health risks.

Avoid Interactions

Drospirenone and Ethinyl Estradiol Tablets may interact with certain medications, including antibiotics, antifungal drugs, and seizure medications. Always inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using these tablets.

Frequently Asked Questions

These tablets are primarily used for birth control and managing menstrual irregularities.

These tablets are taken orally, typically once daily, as directed by a healthcare provider.

Common side effects may include nausea, breast tenderness, headaches, and changes in menstrual bleeding patterns.

These tablets are not recommended for use during pregnancy. Consult a healthcare provider for guidance.

If you miss a dose, follow the instructions provided by your healthcare provider or the medication guide.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.